Delivery system for drug and cell therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/28 (2006.01) A61K 9/00 (2006.01) A61K 47/36 (2006.01)

Patent

CA 2518143

A method of lowering blood glucose in a mammal includes administering orally or by injection or inhalation a therapeutically effective amount of crystallized dextran microparticles and insulin to the mammal to lower blood glucose of the mammal. The composition may be a one phase or a structured multi-phase composition for controlled release of insulin or other therapeutic agents.

Selon ce procédé pour faire baisser le niveau de glucose dans le sang d'un mammifère, on administre par voie orale, par injection ou par inhalation une quantité thérapeutiquement efficace de microparticules de dextrane cristallisé et d'insuline au mammifère afin de faire baisser le niveau de glucose dans le sang du mammifère. La composition peut présenter une seule phase ou une pluralité de phases structurées pour libérer l'insuline ou d'autres agents thérapeutiques de façon contrôlée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Delivery system for drug and cell therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Delivery system for drug and cell therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery system for drug and cell therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1983078

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.